Geburtshilfe Frauenheilkd 2022; 82(10): e165-e166
DOI: 10.1055/s-0042-1757060
DOI: 10.1055/s-0042-1757060
Abstracts | DGGG
Prevalence and clinical characterization of concurrent multiple deleterious germline mutations in German patients with epithelial ovarian cancer
Autor*innen
-
C Staniczok
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland2 LMU Munich, University Hospital, Department of Obstetrics and Gynecology, Munich, Deutschland -
B Ataseven
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland2 LMU Munich, University Hospital, Department of Obstetrics and Gynecology, Munich, Deutschland -
F Heitz
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland3 Charité – Universitätsmedizin Berlin, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Berlin, Deutschland -
P Harter
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland -
K Rhiem
4 University Hospital Cologne, Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Cologne, Deutschland -
N Pauly
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland2 LMU Munich, University Hospital, Department of Obstetrics and Gynecology, Munich, Deutschland -
A Traut
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland -
M Moubarak
1 Kliniken Essen Mitte, Department of Gynecology and Gynecological Oncology, Essen, Deutschland

